An Open-Label, Randomized, Crossover Study to Evaluate the Bioavailability of Two Candidate Tablet Formulations of ABT-072 With Reference to the Capsule Formulation.
Phase of Trial: Phase I
Latest Information Update: 19 Oct 2010
At a glance
- Drugs ABT 072; ABT 072
- Indications Hepatitis C
- Focus Pharmacokinetics
- 02 Sep 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 04 Aug 2009 New trial record